Surgicount – NASDAQ: PSTX SurgiCount Medical is a developer and provider of patient safety products and services. The company's flagship product offering, the Safety-Sponge System, is designed to prevent the occurrence of surgical sponges, laps and towels from being left inside patients after surgery.
Patient Safety Technologies, Inc. focuses on the development, marketing and sale of products designed to improve patient outcomes and reduce costs in the healthcare industry. The Company conducts its business through its wholly owned subsidiary, SurgiCount Medical, Inc. The Company's Safety-Sponge System is designed to eliminate one of the most common errors in surgery, retained surgical sponges, and the human and economic costs associated with this surgical mistake. The Safety-Sponge System consists of a line of identified surgical sponges and towels and a turnkey hardware and software offering integrated to form a accounting and documentation system.
Management President and Chief Executive Officer - Brian E. Stewart is the co-founder of our sole operating subsidiary, SurgiCount Medical, Inc., and co-inventor of our Safety-Sponge ® System. After selling SurgiCount Medical to Patient Safety Technologies, Inc. in 2005, Mr. Stewart acted as an advisor to the company and remained one of the largest individual shareholders of Patient Safety Technologies. In 2010 Mr. Stewart spearheaded a shareholder activism effort supported by the majority of the shareholders of Patient Safety Technologies which directly resulted in the resignation of the then majority of the board of directors, the replacement of senior management and the appointment of Mr. Stewart as our President and Chief Executive Officer. Previously, Mr. Stewart worked in the investment banking divisions of Credit Suisse, CIBC World Markets and Donaldson, Lufkin & Jenrette. In addition to his investment banking and entrepreneurial experience, Mr. Stewart's previous experience includes Strome Investment Management, a hedge fund in Santa Monica, CA. Mr. Stewart received his MBA from The Anderson School at UCLA and his BA in Economics from UCLA where he graduated Phi Beta Kappa and Summa Cum Laude. Mr. Stewart has received numerous issued domestic and international patents, including all the patents protecting the Safety-Sponge ® System.
VP, Finance, CFO - David Dreyer - Mr. Dreyer is the Company’s Chief Financial Officer and Vice President, having joined the Company in October of 2010. Previously, Mr. Dreyer was Chief Financial Officer at Alphastaff Inc., from August 2009 through September 2010, and Chief Financial Officer, Chief Administrative Officer and Treasurer at AMN Healthcare, Inc. from August 2004 through August 2009. Alphastaff is the fourth-largest professional employment outsourcing company in the United States, with annual revenue of approximately $250 million. He managed over one hundred employees at AMN in his role overseeing finance, accounting, tax, investor relations, treasury, payroll operations and risk management. Prior to working for AMN Healthcare, Inc., Mr. Dreyer was Chief Financial Officer at Sicor Inc., a specialty pharmaceutical company headquartered in Irvine, CA with operations in Mexico, Switzerland, Italy, China and Lithuania. David led the sale of Sicor Inc. to Teva Ltd. for $3.4 billion in January 2004.
VP, Sales and Clinical Field Operations - Tony Embree brings over 27 years of sales, sales management, and procedural supply chain consulting experience in hospital operating rooms and the procedural area environment. Previous experience includes 24 years with Cardinal Health in a variety of leadership positions that have prepared him for his current role. Tony joined the company in January, 2008 and has played a key role in driving adaptation of the Safety Sponge System while serving as Midwest Area Vice President. Additional entrepreneurial experience includes co-founding and launching a medical technology company from concept to market.
VP, Business/Product Development – Nicolas Soichet has led several departments since the founding of Company including business development, research & development, and marketing. He lead the development of the Safety-Sponge™ and Citadel™ products, the development of the Company’s proprietary sponge manufacturing processes, as well as the expansion of its IP portfolio. Mr. Soichet currently oversees overall development. His business background encompasses investment banking, strategic operations, and manufacturing.